Insulin lispro (Lys(B28), Pro(B29)) in the treatment of diabetes during the fasting month of Ramadan
- 1 October 1999
- journal article
- clinical trial
- Published by Wiley in Diabetic Medicine
- Vol. 16 (10), 867-874
- https://doi.org/10.1046/j.1464-5491.1999.00164.x
Abstract
To compare insulin lispro with soluble human insulin in patients with Type 2 diabetes mellitus fasting during Ramadan, with respect to the rate of hypoglycaemic episodes and postprandial blood glucose values after the main meal after sunset. The insulins were compared in an open-label, randomized, cross-over study of 70 outpatients. Hypoglycaemic episodes were recorded by the patients in a self-monitoring diary. Fasting, 1-h and 2-h postprandial blood glucose values were recorded by the patient on three consecutive days at the end of each treatment period. The fasting blood glucose values before sunrise (P>0.4) and after sunset (P>0.6) were similar and did not differ significantly between both treatment groups. The rise in blood glucose after the main meal after sunset was 3.0+/-0.4 mmol/l after 1 h in the insulin lispro treatment group compared to 4.3+/-0.4 mmol/l in the soluble insulin treatment group (P<0.01), and 2.6+/-0.4 mmol/l after 2h with insulin lispro compared to 4.0+/-0.5 mmol/l with soluble insulin (P<0.008). Mean hypoglycaemic episodes per patient over 14 days were 1.3+/-0.1 vs. 2.6+/-0.2, P<0.002, respectively, for insulin lispro and soluble insulin. Most hypoglycaemic episodes occurred during the time period from 6 h after the before sunrise meal until breaking the fast after sunset. The significantly lower rate of hypoglycaemic episodes combined with better control of postprandial blood glucose suggest insulin lispro may be more suitable prandial insulin for patients treated with Type 2 diabetes who fast during Ramadan.Keywords
This publication has 14 references indexed in Scilit:
- Metabolic Efficacy of Preprandial Administration of Lys(B28), Pro(B29) Human Insulin Analog in IDDM Patients: A comparison with human regular insulin during a three-meal test periodDiabetes Care, 1997
- Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study GroupArchives of Internal Medicine, 1997
- Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog TreatmentDiabetes, 1997
- Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell FunctionDiabetes Care, 1995
- [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human InsulinDiabetes, 1994
- The fast of Ramadan.BMJ, 1992
- CLINICAL PROBLEMS DURING FAST OF RAMADANThe Lancet, 1989
- Diabetes Mellitus and Ramadan Fasting: The Need for a Critical AppraisalDiabetic Medicine, 1988
- Insulin PharmacokineticsDiabetes Care, 1984
- Muslims, Ramadan, and diabetes mellitus.BMJ, 1979